Want to see KR:192820 full AI Analyst Report?
Top Page
COSMAX, Inc.
(192820)
Select Model
Select Model
Rating:60Neutral
Price Target:
$276,675
Action:N/A
Date:10/28/26
The score is held back mainly by weak cash generation and elevated leverage despite strong recent profitability improvements. Technical indicators also point to soft momentum. Valuation is reasonable (P/E ~15.6 with a modest dividend), providing partial support but not enough to outweigh cash-flow and balance-sheet risk.
Positive Factors
Sustained Revenue Growth
The multiyear revenue increase indicates expanding demand for COSMAX’s cosmetics development and manufacturing services. Continued top-line growth can support operating scale, strengthen customer relationships, and provide a durable foundation for reinvestment across skincare, makeup, and personal care categories.
Negative Factors
Elevated Leverage
High and rising leverage increases COSMAX’s sensitivity to financing costs and reduces balance-sheet flexibility. Greater debt obligations can constrain capital allocation and make it harder to absorb weaker operating conditions, even though returns and profitability have recently improved.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth
The multiyear revenue increase indicates expanding demand for COSMAX’s cosmetics development and manufacturing services. Continued top-line growth can support operating scale, strengthen customer relationships, and provide a durable foundation for reinvestment across skincare, makeup, and personal care categories.
Read all positive factors
COSMAX, Inc. (192820) vs. SPDR S&P 500 ETF (SPY)
Market Cap
₩2.80T
Dividend Yield1.34%
Average Volume (3M)84.89K
Price to Earnings (P/E)14.6
Beta (1Y)0.15
Revenue Growth15.81%
EPS Growth197.32%
CountryKR
Employees1,565
SectorGeneral
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)16944.17
Shares Outstanding11,349,509
10 Day Avg. Volume89,093
30 Day Avg. Volume84,887
Financial Highlights & Ratios
PEG Ratio0.35
Price to Book (P/B)3.31
Price to Sales (P/S)0.77
P/FCF Ratio-18.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₩370,000.00Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)15,238.71
Revenue Forecast (FY)₩3.05T
COSMAX, Inc. Business Overview & Revenue Model
Company Description
Cosmax, Inc. operates as a global entity engaged in the research, development, manufacturing, and distribution of a broad spectrum of goods, including cosmetic items, nutritional supplements, and pharmaceutical products. Its comprehensive beauty p...
COSMAX, Inc. Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
58
Neutral
Cash Flow
34
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.66T | 2.40T | 2.17T | 1.78T | 1.60T | 1.59T |
| Gross Profit | 428.49B | 395.42B | 418.21B | 367.61B | 205.27B | 277.51B |
| EBITDA | 297.55B | 269.72B | 251.79B | 175.77B | 86.17B | 147.62B |
| Net Income | 184.27B | 123.06B | 85.80B | 57.14B | -16.45B | 34.34B |
Balance Sheet | ||||||
| Total Assets | 2.67T | 2.13T | 1.93T | 1.56T | 1.40T | 1.41T |
| Cash, Cash Equivalents and Short-Term Investments | 353.30B | 223.01B | 288.65B | 286.39B | 181.37B | 184.36B |
| Total Debt | 1.09T | 824.67B | 749.14B | 597.04B | 607.87B | 563.25B |
| Total Liabilities | 1.96T | 1.51T | 1.42T | 1.20T | 952.20B | 946.54B |
| Stockholders Equity | 646.59B | 558.16B | 473.40B | 362.52B | 581.13B | 561.31B |
Cash Flow | ||||||
| Free Cash Flow | -60.16B | -100.26B | -95.56B | 140.94B | 18.17B | 57.94B |
| Operating Cash Flow | 167.33B | 86.70B | 72.97B | 231.02B | 102.53B | 100.05B |
| Investing Cash Flow | -200.19B | -179.43B | -160.03B | -104.50B | -31.25B | -143.69B |
| Financing Cash Flow | 133.66B | 28.33B | 67.52B | -39.18B | 3.47B | 32.50B |
COSMAX, Inc. Technical Analysis
Neutral
―
Price Trends
276130.00
Negative
227603.00
Positive
208393.82
Positive
Market Momentum
-5038.06
Positive
34.96
Neutral
11.73
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:192820, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 278150.00, equal to the 50-day MA of 276130.00, and equal to the 200-day MA of 208393.82, indicating a neutral trend. The MACD of -5038.06 indicates Positive momentum. The RSI at 34.96 is Neutral, neither overbought nor oversold. The STOCH value of 11.73 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for KR:192820.
COSMAX, Inc. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | ₩209.73B | 3.78 | ― | 3.55% | 25.12% | 295.70% | |
60 Neutral | ₩2.80T | 14.58 | ― | 1.34% | 15.81% | 197.32% | |
60 Neutral | ₩260.74B | 15.08 | ― | 1.93% | 4.00% | -46.33% | |
56 Neutral | ₩2.66T | 14.36 | ― | 0.77% | 12.57% | 90.44% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | ₩3.84T | -71.35 | -1.34% | 0.96% | -5.12% | -165.36% | |
50 Neutral | ₩204.92B | -243.15 | ― | 0.77% | -8.83% | -111.22% |
* General Sector Average
KR:192820
COSMAX, Inc.
247,000.00
45,791.95
22.76%
KR:051900
LG Household & Health Care
259,500.00
-22,496.90
-7.98%
KR:018250
Aekyung Industrial Co., Ltd.
10,350.00
-3,476.86
-25.15%
KR:044820
Cosmax BTI Inc.
21,950.00
8,377.02
61.72%
KR:161890
KOLMAR KOREA CO. LTD
112,500.00
36,335.77
47.71%
KR:200130
KolmarBNH Co., Ltd.
7,410.00
-6,368.25
-46.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.